Optimizing Lipid Management in Internal Medicine: Applying the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline (2026 AC Live)

Only available as part of a package

Learning Objectives:

Apply the 2026 ACC/AHA/Multisociety dyslipidemia framework to assess cardiovascular risk and select appropriate LDL-C and non-HDL-C treatment goals.
Use PREVENT risk estimates, coronary artery calcium scoring, risk-enhancing factors, ApoB, and lipoprotein(a) to personalize lipid-management decisions.
Select and sequence statin and nonstatin therapies based on ASCVD risk, degree of LDL-C lowering needed, triglyceride burden, medication tolerance, adherence, and access.

Chad A. Link, DO, FACC, FACOI

Cardiologist

University of Michigan Health- Sparrow

Chad A. Link, D.O. FACC, FACOI received his medical degree from Michigan State University’s College of Osteopathic Medicine in East Lansing, Michigan. He completed both his Internal Medicine Residency and Cardiology Fellowship at Ingham Regional Medical Center in Lansing, Michigan. He is board certified in Internal Medicine, Cardiology and Nuclear Cardiology and serves as the cardiology chairman for the University of Michigan Health System-Sparrow Eaton and Ionia Hospitals and is a clinical assistant professor for the cardiology course at Michigan State University’s College of Osteopathic Medicine.

He specializes in cardiovascular medicine with the University of Michigan Health-Sparrow. Dr. Link’s background includes all aspects of clinical cardiology with specialized interest in the management of coronary artery disease, hyperlipidemia, echocardiography; nuclear cardiology and pulmonary hypertension. Professional memberships include: the American Society of Echocardiography, the American College of Cardiology, and the American Society of Nuclear Cardiology.

The faculty member, for this activity, has disclosed the following financial relationships: